Unknown NA INTERVENTIONAL 3-arm NCT05315024

Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children

Prevalence, Genetic Risk Factor and the Use of Intradermally-administered Inactivated Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children

Sponsor: The University of Hong Kong

Conditions Influenza

Interventions Fluarix Tetra Imiquimod cream

Updated 4 times since 2022 Last updated: Apr 10, 2022 Started: Apr 30, 2022 Primary completion: Sep 30, 2023 Completion: Oct 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05315024, this NA trial focuses on Influenza and remains ongoing. Sponsored by The University of Hong Kong, it has been updated 4 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
May 2022 — May 2024 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Hong Kong

Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.